KRMN Q1 2026 Earnings EPS Miss Sends Shares Lower Amid Operational Challenges Day One Biopharmaceuticals DAWN Q4 2025 Earnings EPS Miss Reflects RD Spend Amid PreRevenue Status FormFactor Q1 2026 Earnings EPS Beats Estimates by Wide Margin Safehold Inc SAFE Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction BG Q1 2026 Earnings Earnings Surge 103 Above Estimates as Agribusiness Strength Outpaces Expectations CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline